Sort by
Refine Your Search
-
Fribourg campus, with access to EPFL facilities and research infrastructure in both Fribourg and Lausanne. Additional information For more information about HOBEL: https://www.epfl.ch/labs/hobel/ For more
-
conducts applied and theoretical research on the economics and politics of sustainable development, as well as the policies to achieve it. More information at: https://www.epfl.ch/labs/pasu/ . We are looking
-
: https://www.epfl.ch/labs/hobel/ For more information about Prof. Dusan Licina: https://people.epfl.ch/dusan.licina For more information about EPFL: https://www.epfl.ch/en/ For more information about Smart
-
the earth sciences. NCCR Genesis does not aim to provide answers in all fields, but to drive innovative research and achieve decisive progress. Details on NCCR Genesis are available on its website https
-
opportunities for technology transfer and innovation Competitive salary and excellent working conditions - more information can be found on our website (https://www.epfl.ch/campus/services/human-resources/en
-
Foster ([email protected]) - https://laser.epfl.ch/ Contract Start Date : 01.12.2026, or to be determined Activity Rate : 100.00 Contract Type: CDD Duration: 1 year, renewable Reference: 2464
-
than 18,500 people, including over 14,000 students and 4,000 researchers from more than 120 different countries. Postdoc in ML-Based Co-Design at EPFL Mission The EPFL computer vision lab (https://www.epfl.ch
-
positions. https://www.epfl.ch/labs/entc/ Education You will work closely with Dr. Davide Bavato, head of EPFL’s recently established Entrepreneurship Education Hub. The Hub is developing a structured
-
information can be found on https://laser.epfl.ch/. Contract Start Date : 01.12.2026, or to be determined Activity Rate : 100.00 Contract Type: CDD Duration: 1 year, renewable (project duration permitting
-
protocols. In close collaboration with the lab of George Coukos (https://agora-cancer.ch/laboratory/coukos-lab/ ), we will derive protocols enabling rapid expansion of cancer-specific, autologous TILs